David A. Geier, BA.
Researcher – Toxicology / Epidemiology / Biochemistry
Institute of Chronic Illnesses, Inc.
14 Redgate Ct.
Silver Spring, MD 20905
Mr. David A. Geier graduated with honors from the University of Maryland, Baltimore County (UMBC) with a BA in biology and a minor in history. Subsequently, he undertook graduate studies in the fields of immunology, epidemiology, biochemistry, infectious diseases, and vaccines from the Foundation for Advanced Education in the Sciences, Inc at the National Institutes of Health (NIH) and the George Washington University.
Mr. Geier’s extensive research experience has involved cellular molecular-biology studies, large population observational epidemiological studies, and human placebo-controlled randomized clinical trials. Mr. David A. Geier has published more than 100 peer-reviewed scientific/medical studies in academic journals and medical textbook chapters. Mr. Geier’s research has repeatedly been published in such prestigious academic journals as Experimental Biology and Medicine, Expert Opinion on Drug Safety, Expert Opinion on Pharmacotherapy, and Expert Review of Molecular Diagnostics.
As a result of the importance of Mr. Geier’s research, he was invited to address the Institute of Medicine of the United States National Academy of Sciences on several occasions regarding vaccine safety, vaccine policy, and the relationship between Thimerosal and autism. He has also been invited to address numerous academic conferences in the United States and worldwide regarding the results of his research. Mr. Geier was also an accredited participant in the Intergovernmental Negotiating Committee meetings of the United Nations Environmental Programme on helping to prepare a global legally binding instrument on mercury, the “Minamata Convention on Mercury“.
Mr. David A. Geier is one of original co-founders and co-directors of the non-profit 501(c)3 Institute of Chronic Illnesses, Inc. foundation (founded in 2006), which has raised more than more than a million dollars in grants and donations since its inception by various esteemed individuals and non-profit foundations such as the Autism Research Institute, the Strategic Autism Initiative, the Brenen Hornstein Autism Research and Education Foundation, and the International Academy of Oral Medicine and Toxicology, and helped to support the publication of more than 40 scientific/medical research studies in peer-reviewed academic and medical journals. Dr. Geier is also one of original co-founders and co-directors of the non-profit 501(c)3 CoMeD, Inc, foundation (founded in 2007), which has received several hundred thousands of dollars of donations and grants since its inception by various esteemed individuals and non-profit foundations to support its extensive educational efforts.